19.96%SPY 79.52 
5.39%XLF 9.68 3.09%
Digg
Del.icio.us
Newsvine 
Facebook
Stumbleupon
SAN DIEGO - Genetic analysis company Illumina Inc. said Tuesday it will buy privately held Avantome Inc. for $25 million upfront in order to boost its genetic sequencing technologies.
| ILMN | 19.83 |  -1.2 |
Illumina said it will make a $25 million cash payment and contingent payments up to $35 million for the company. Avantome's principal founders, Mostafa Ronaghi and Helmy Eltoukhy, will join Illumina's management.
Ronaghi will become senior vice president and chief technical officer and Eltoukhy will become director of Avantome sequencing development.
The deal is expected to close in the next few weeks.
Shares jumped $3.40, or 4 percent, to $87.50 in after-hours trading. The stock rose 6 cents to close at $84.10 during the regular trading session.
The Internet giant is opting for 'smaller team-focused parties'
As more Americans rely on charity amid worsening economic gloom, operators of fo...
Betty James, who co-founded the company that made the Slinky and beat the odds as a single mother in the late 1950s to become a successful execut...
Baldwin Linguas:
Translations Interpreting Localization:
English French Portuguese Spanish
Split Big Profits! You Find it & We Fund it! Co-Own Or Cash Out! Get Free Info Kit Now!
Get your next web design project done with our los angeles web design team - Best web design with great price.
Partners   
|
© 2008 The Ibtimes Company. All Rights Reserved. Terms of service | Privacy Policy | Advertising | About Us | Contact Us | Archives
EMAIL
PRINT
RSS
SHARE
